Amanote Research
Register
Sign In
217. Lentiviral shRNA Targeting NANOG/NANOGP8 Enhances Topotecan Chemotherapy in Human Colorectal Carcinomas
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34552-x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
Bone Marrow Tolerance During Postoperative Chemotherapy in Colorectal Carcinomas
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
Plasmid-Based shRNA Lentiviral Particle Production for RNAi Applications
Journal of Biomolecular Screening
Molecular Medicine
Pharmacology
Biochemistry
Analytical Chemistry
Biotechnology
Drug Discovery
Intra-Tumor Injection of Lentiviral-Vector Delivered shRNA Targeting Human Papillomavirus E6 and E7 Oncogenes Reduces Tumor Growth in a Xenograft Cervical Cancer Model in Mice
Journal of Solid Tumors
Cancer Research
Oncology
Radiology
Nuclear Medicine
Imaging
Effect of shRNA‑mediated Inhibition of Nanog Gene Expression on the Behavior of Human Gastric Cancer Cells
Oncology Letters
Cancer Research
Oncology
Topotecan Monotherapy in Heavily Pretreated Patients With Progressive Advanced Stage Neuroendocrine Carcinomas
Journal of Cancer
Oncology
MicroRNA 217 Inhibits Cell Proliferation and Enhances Chemosensitivity to Doxorubicin in Acute Myeloid Leukemia by Targeting KRAS
Oncology Letters
Cancer Research
Oncology
A Multi-shRNA Vector Enhances the Silencing Efficiency of Exogenous and Endogenous Genes in Human Cells
Oncology Letters
Cancer Research
Oncology
Altered mRNA Expression of Glycosyltransferases in Human Colorectal Carcinomas and Liver Metastases
Gut
Gastroenterology
Topotecan Combination Chemotherapy in Two New Rodent Models of Retinoblastoma
Clinical Cancer Research
Cancer Research
Oncology
